Skip to main content
Caplight Logo









Xyne

Xyne

Private
Lewes, DelawareAI, Data & Cloud Infrastructurehttps://xynehq.com/

Last Round

Seed

Aug 1, 2022

Total Funding Raised

$2.5M

Company Overview

Xyne operates in AI, Data & Cloud Infrastructure and is based in Lewes, Delaware. Its latest recorded funding round was a Seed round in August 2022.

Xyne is a business software company that provides an AI-first search and answer engine designed to help enterprises index and retrieve information across various SaaS applications.

Sector

AI, Data & Cloud Infrastructure

Verticals

NLP & Conversational AI, Data Integration, Workflow Automation, Business Intelligence, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Xyne Comparables

Compare Xyne with similar companies based on industry and business-model similarity.

Xyne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Onyx
92%
PipesHub
88%
GoSearch
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Xyne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Shekhar Gurav

CEO & Co-founder

Founding Team

For institutional investors. Book with your work email.

Xyne Investors

Notable investors and investment history

Xyne investors
InvestorRounds
Better CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 617% MoM, reaching 1.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Xyne Filings

Explore SEC and related filing metadata, where available.

Xyne filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Xyne's valuation, stock price, and market status.

Is Xyne a public or private company?

Xyne is a private company.

What is the current stock price of Xyne?

Xyne is a private company, so its shares have no public market price. Caplight tracks Xyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Xyne worth (valuation)?

Valuation information for Xyne is not publicly available.

Can I buy Xyne stock?

Xyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Xyne's last funding round?

Xyne's most recent funding round was Seed on August 1, 2022.

Who are the main investors in Xyne?

Key investors in Xyne include Better Capital.

Will Xyne IPO soon?

No public IPO plans have been announced for Xyne.

How can I track Xyne secondary market activity?

Caplight tracks bids, offers, and trades in Xyne's shares on secondary markets.

Firmographic Details

HeadquartersLewes, Delaware
Employee Range5
Year Founded2023
Last FundingAug 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?